Skip to content


Synarel (nafarelin) is a protein pharmaceutical. Nafarelin was first approved as Synarel on 1990-02-13. It is used to treat endometriosis and precocious puberty in the USA. The pharmaceutical is active against gonadotropin-releasing hormone receptor.
Trade Name Synarel
Common Name Nafarelin
Indication endometriosis, precocious puberty
Drug Class Prehormones or hormone-release stimulating peptides
Get full access now